期刊文献+

老年直肠癌患者盆腔放疗的急性血液学毒性 被引量:2

Acute hematologic toxicity in elderly rectal cancer patients treated with pelvic radiotherapy
原文传递
导出
摘要 目的 探究老年直肠癌患者盆腔放疗的急性血液学毒性反应的发生率及其影响因素。方法 回顾分析2006年1月至2014年8月在本院行盆腔放疗的50例75岁及以上直肠癌患者的临床资料。选取同一时期行盆腔放疗的111例75岁以下直肠癌患者作为非老年患者组进行比较。采用卡方检验及Logistic多因素回归模型分析不同临床因素与3~4度血液学毒性发生率的相关性。结果 老年患者组中0度、1~2度、3~4度急性血液学毒性发生率分别为6.0%、78.0%和16.0%,非老年患者组中0度、1~2度、3~4度急性血液学毒性发生率分别为24.3%、68.5%和7.2%。老年患者的3~4血液学毒性反应发生率高于非老年患者(P=0.009)。多因素分析显示体重指数与老年患者的3~4度急性血液学毒性反应发生显著相关(P=0.038)。结论 老年直肠癌患者盆腔放疗的急性血液学毒性反应是可耐受的,高体重指数可能与老年患者盆腔放疗的严重血液学毒性反应相关。 Objective To explore the incidence and influential factors of acute hematologic toxicity in elderly rectal cancer patients treated with pelvic radiotherapy. Methods Fifty elderly patients aged 75 and older with rectal cancer, who were treated with pelvic radiotherapy at our hospital, were retrospectively analyzed. 111 non-elderly patients under 75 years of age, who were treated with pelvic radiotherapy in the same period, were selected as a control group. The relationship between clinical characteristics and incidence of grade 3~4 hematologic toxicity were analyzed by using chi-square test and multinomial logistic regression.Results In the elderly patient group, the incidence of grade 0, grade 1~2, grade 3~4 hematologic toxicity were 6.0%, 78.0%, and 16.0%, respectively. In the non-elderly patient group, the incidence of grade 0,grade 1~2, grade 3~4 hematologic toxicity were 24.3%, 68.5%, and 7.2%, respectively. The incidence of grade 3~4 hematologic toxicity in elderly patients was higher than that in non-elderly patients (P=0.009).Multivariate analysis showed that the body mass index was significantly correlated with the incidence of grade 3~4 hematologic toxicity in elderly patients (P=0.038). Conclusions Acute hematologic toxicity induced by pelvic radiotherapy was well tolerated in elderly patients with rectal cancer. High body mass index may be associated with severe hematologic toxicity in elderly patients.
作者 沈金闻 朱远 刘鲁迎 刘鹏 罗加林 汤忠祝 Shen jinwen;Zhu yuan;Liu luying;Liu Peng;Luo Jialin;Tang Zhongzhu(Department of Radiation Oncology,Zhejiang Cancer Hospital, Hangzhou 310022, China)
出处 《中华结直肠疾病电子杂志》 2015年第6期633-640,共8页 Chinese Journal of Colorectal Diseases(Electronic Edition)
基金 浙江省医药卫生科技计划基金资助(2012KYA022)
关键词 直肠肿瘤 老年人 辐射效应 Rectal neoplasms Aged Radiation effects
  • 相关文献

参考文献13

  • 1Glimelius B, Tiret E, Cervantes A, et al. Rectal cancer: ESMOClinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol, 2013, 24 Suppl 6: vi81-88.
  • 2Papamichael D, Audisio RA, Glimelius B, et al. Treatment ofcolorectal cancer in older patients: International Society of GeriatricOncology (SIOG) consensus recommendations 2013. Ann Oncol,2015, 26(3): 463-476.
  • 3Ellis RE. The distribution of active bone marrow in the adult. PhysMed Biol, 1961, 5: 255-258.
  • 4Yang TJ, Oh JH, Apte A, et al. Clinical and dosimetric predictorsof acute hematologic toxicity in rectal cancer patients undergoingchemoradiotherapy. Radiother Oncol, 2014, 113(1): 29-34.
  • 5Bazan JG, Luxton G, Kozak MM, et al. Impact of chemotherapy onnormal tissue complication probability models of acute hematologictoxicity in patients receiving pelvic intensity modulated radiationtherapy. Int J Radiat Oncol Biol Phys, 2013, 87(5): 983-991.
  • 6Sauer R, Becker H, Hohenberger W, et al. Preoperative versuspostoperative chemoradiotherapy for rectal cancer. N Engl J Med,2004, 351(17): 1731-1740.
  • 7Wang J, Myles B, Wei C, et al. Obesity and outcomes in patientstreated with chemoradiotherapy for esophageal carcinoma. DisEsophagus, 2014, 27(2): 168-175.
  • 8Albuquerque K, Giangreco D, Morrison C, et al. Radiation-relatedpredictors of hematologic toxicity after concurrent chemoradiationfor cervical cancer and implications for bone marrow-sparing pelvicIMRT. Int J Radiat Oncol Biol Phys, 2011, 79(4):1043-1047.
  • 9Tougeron D, Roullet B, Paillot B, et al. Safety and outcome ofchemoradiotherapy in elderly patients with rectal cancer: resultsfrom two French tertiary centres. Dig Liver Dis, 2012, 44(4):350-354.
  • 10De Felice F, Musio D, Izzo L, et al. Preoperative chemoradiotherapyin elderly patients with locally advanced rectal cancer. Biomed ResInt, 2013, 610786.

二级参考文献8

  • 1Medical Research Council Rectal Cancer Working Party. Randomized trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of rectum. Lancet, 1996,348:1610-1614.
  • 2Fisher B, Wolmark N, Rockette H, et al. Postoperative adjuvant chemotherapy o r radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst,1988,80:21-29.
  • 3Arnaud J, Nordlinger B, Bosset J, et al. Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase Ⅲ study of the European Organization for Research and Treatment of Cancer. Br J Surg, 1997,84:352-357.
  • 4Treurniet-Donker A, van Putten W, Wereldsma J, et al. Postoperative radiation therapy for rectal cancer. An interim analysis of a prospective, randomized multicenter trial in the Netherlands. Cancer,1991,67:2042-2048.
  • 5Balslev I, Pedersen M, Teglbjaerg P, et al. Postoperative radiotherapy in Du cks' B and C carcinoma of the rectum and recto-sigmoid. A randomized multicente r study. Cancer,1986,58:22-28.
  • 6Thomas P, Lindblad A. Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: a review of the Gastro-intestinal Tumor Study Group experience. Radiother Oncol, 1988,13:245-252.
  • 7Zelefsky MJ,Leibel SA,Kutcher GJ,et al. Three-dimensional conformal radiotherapy and dose escalation:where do we stand? Semin Radiat Oncol,1998,8:107 -114.
  • 8于金明,李宝生.调强放射治疗研究进展[J].中华放射肿瘤学杂志,2001,10(4):279-282. 被引量:20

共引文献50

同被引文献10

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部